Abstract

In this case report, we discuss a 22-year-old female patient with diagnosis of migraine who developed high myopia and choroidal effusion after 7 days of treatment with topiramate. The anterior chamber parameters that induced myopia and choroidal effusion were demonstrated by using ultrasonic biomicroscopy. We aimed to augment the knowledge of the neurologists, psychiatrists and ophthalmologists about the plausible complications of topiramate treatment. The patients under topiramate theraphy must be warned about terminating treatment and consulting to an ophthalmologist immediately when visual symptoms emerged.

Key words: Topiramate, choroidal disaese, miyopia, ultrasonic biomicroscopy